SPONSOR
Ningbo No. 1 Hospital
Total Trials
2
Recruiting
2
Phases
Phase 1
Conditions studied: Diffuse Large B-cell LymphomaUreter InjuryUrolithiasis; Lower Urinary TractEfficacy, Self
Ningbo No. 1 Hospital is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Diffuse Large B-cell Lymphoma, Ureter Injury, Urolithiasis; Lower Urinary Tract, Efficacy, Self.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Ningbo No. 1 Hospital
How many clinical trials has Ningbo No. 1 Hospital sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Ningbo No. 1 Hospital, of which 2 are actively recruiting participants. These trials cover conditions including Diffuse Large B-cell Lymphoma, Ureter Injury, Urolithiasis; Lower Urinary Tract. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ningbo No. 1 Hospital research focus on?
Ningbo No. 1 Hospital clinical trials span Diffuse Large B-cell Lymphoma, Ureter Injury, Urolithiasis; Lower Urinary Tract, Efficacy, Self. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Ningbo No. 1 Hospital clinical trial?
To participate in a Ningbo No. 1 Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ningbo No. 1 Hospital trials with current recruitment status updated daily.
Clinical Trials by Ningbo No. 1 Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology